Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and Cancer of Stomach

edotreotide has been researched along with Cancer of Stomach in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergsma, H; de Herder, WW; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Peeters, RP; Teunissen, JJ; van Vliet, EI1
Cacciari, G; Campana, D; Capurso, G; Delle Fave, G; Falconi, M; Nori, F; Panzuto, F; Partelli, S; Tamburrino, D; Tomassetti, P1
Cappellani, A; Cardì, F; Cavallaro, A; Cavallaro, M; Di Carlo, I; Di Mattia, P; Di Vita, M; Lo Menzo, E; Piccolo, G; Zanghì, A1
Hartmann, H; Luboldt, HJ; Luboldt, W; Wiedemann, B; Zöphel, K1

Other Studies

5 other study(ies) available for edotreotide and Cancer of Stomach

ArticleYear
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.
    Best practice & research. Clinical gastroenterology, 2012, Volume: 26, Issue:6

    Topics: Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Retreatment; Somatostatin; Stomach Neoplasms; Yttrium Radioisotopes

2012
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:8

    Topics: Aged; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Stomach Neoplasms; Treatment Outcome; Yttrium Radioisotopes

2013
The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
    International journal of surgery (London, England), 2014, Volume: 12 Suppl 1

    Topics: Aged; Diagnosis, Differential; Female; Gallium; Gastrectomy; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed

2014
Gastroenteropancreatic neuroendocrine tumors: standardizing therapy monitoring with 68Ga-DOTATOC PET/CT using the example of somatostatin receptor radionuclide therapy.
    Molecular imaging, 2010, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Somatostatin; Reference Standards; Stomach Neoplasms; Tomography, X-Ray Computed

2010
SNM 2012 image of the year.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:10

    Topics: Bismuth; Humans; Intestinal Neoplasms; Liver; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radionuclide Imaging; Societies, Scientific; Stomach Neoplasms; Treatment Failure

2012